نتایج جستجو برای: daunorubicin dosage

تعداد نتایج: 105851  

Journal: :Cancer research 1989
J Lutzky M B Astor R N Taub M A Baker K Bhalla J E Gervasoni M Rosado V Stewart S Krishna A A Hindenburg

We studied the cellular enzymatic defenses against anthracycline-induced free radical damage in the HL60 human myelogenous leukemia cell line and in its anthracycline-resistant subline, HL60/AR. Intracellular glutathione (GSH) levels and gamma-glutamyl transpeptidase activity were lower in HL60/AR than in HL60 cells. Glutathione-S-transferase (GST) and glutathione peroxidase activities were sim...

Journal: :Physiological research 2004
L Schröterová H Kaiserová V Baliharová J Velík V Gersl E Kvasnicková

A major obstacle to the therapeutic use of anthracyclines, highly effective anticancer agents, is the fact that their administration results in dose-dependent cardiomyopathy. According to the currently accepted hypothesis, anthracyclines injure the heart by generating oxygen free radicals. The ability of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) -...

Journal: :acta medica iranica 0
farhad najmeddin department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. arezoo ahmadi department of anesthesiology and critical care medicine, sina hospital, tehran university of medical sciences, tehran, iran. laleh mahmoudi department of clinical pharmacy, faculty of pharmacy, shiraz university of medical sciences, fars, iran. kourosh sadeghi department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. hossein khalili department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran. alireza ahmadvand research center for rational use of drugs, tehran university of medical sciences, tehran, iran.

high-dose extended-interval dosage (hded) regimen of aminoglycosides is now considered as the standard dosage strategy in sepsis. although safety and efficacy of this dosing regimen is well studied, but new experiments show increased the risk of resistance development associated with %t>mic less than 60% of the dosing interval following extended interval dosing. moreover, limited information is...

Journal: :British Journal of Clinical Pharmacology 2003

2017
Jianyun Zhao Chengzhi Xie Holly Edwards Guan Wang Jeffrey W Taub Yubin Ge

Resistance to chemotherapy and a high relapse rate highlight the importance of finding new therapeutic options for the treatment of acute myeloid leukemia (AML). Histone deacetylase (HDAC) inhibitors (HDACIs) are a promising class of drugs for the treatment of AML. HDACIs have limited single-agent clinical activities, but when combined with conventional or investigational drugs they have demons...

Journal: :Anticancer research 2012
Marta Stojak Lidia Mazur Malgorzata Opydo-Chanek Malgorzata Lukawska Irena Oszczapowicz

BACKGROUND/AIM In the search for new derivatives of anthracycline antibiotics, formamidinodaunorubicins containing in the amidine group either a morpholine moiety (DAUFmor) or a hexamethyleneimine moiety (DAUFhex) were synthesized. The biological effects of daunorubicin (DAU), DAUFmor and DAUFhex were compared. MATERIALS AND METHODS The experiments were performed on human acute lymphoblastic ...

2017
David J. Mathew Anupriya Arthur Sheeja Susan John

Purpose With the advent of more aggressive cytotoxic chemotherapy regimens, the incidence of ocular toxicity due to these drugs is also on the rise. We report a case of Presumed Chemotherapy-Induced optic neuropathy and maculopathy secondary to treatment with cytarabine and daunorubicin for Acute Myeloid Leukaemia (AML). Case report A 50-year-old man with AML developed sudden decrease in visi...

Journal: :British journal of haematology 2010
Thomas R Chauncey Holly Gundacker Mazyar Shadman Alan F List Shaker R Dakhil Harry P Erba Marilyn L Slovak I-Ming Chen Cheryl L Willman Kenneth J Kopecky Frederick R Appelbaum

Attempts to overcome multi-drug resistance in acute myeloid leukaemia (AML) have been limited by toxicities. To investigate the effect of reducing peak drug levels, we performed sequential phase II studies using continuous infusion daunorubicin and cytarabine without (AD) and then with ciclosporin (ADC) in older patients with AML. Untreated patients (age 56+ years) received daunorubicin (45 mg/...

Journal: :Journal of bacteriology 1997
P Kaur

Streptomyces peucetius, a microorganism that produces the anticancer drugs doxorubicin and daunorubicin, is itself resistant to the action of these drugs. The genes conferring resistance to doxorubicin and daunorubicin in S. peucetius have been sequenced (P. G. Guilfoile and R. Hutchinson, Proc. Natl. Acad. Sci. USA 88:8553-8557, 1991). Two open reading frames, drrA and drrB, were proposed to e...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید